Whether it is full pipeline support or standalone analytical projects, you can rely on our deep analytical expertise and commitment to always delivering value-adding data packages and solutions aligned to the latest version guidelines.
Oligonucleotide Research, Development and Manufacturing
We are committed to accelerating the development and manufacturing of your RNA therapeutics. Get in touch now to leverage our 40+ years’ collective oligonucleotide R&D and manufacturing experience, and state-of-the-art facilities.
CatSci have partnered with AGC Pharma Chemicals Europe, a global CDMO. You can harness AGC’s GMP manufacturing capabilities while leveraging CatSci’s CMC expertise to accelerate the delivery of your best-in-class medicines.
From route scouting and selection, initial scale-up and risk management, our fully integrated process chemistry, analytical development, material science and preformulation teams offer tailored solutions to address each and any of your pre-clinical and Phase I demands.
We provide process design, assessment and optimisation, scale-up for clinical and commercial manufacture, tech transfer and post-approval improvements coupled with material science, preformulation and analytical development to de-risk your journey from Phase II and Phase III, right through to product launch and beyond.
Leverage your already available API, project and formulation data sets to assess the risks of your API process and receive a perfect-for-purpose process development roadmap with CatSci’s digital risk assessor, SmartPath.
Pharmaceutical innovation partner providing process chemistry solutions to support the delivery of best-in-class small molecule and oligonucleotides therapeutics.
Who are CatSci
We are an award-winning, fast-growing and agile innovation partner with a proven track record in developing economically and environmentally sustainable pharmaceutical manufacturing processes for global companies of all sizes.
Every day, we leverage our fully integrated process chemistry, analytical development, pre-formulation, material science, HPAPIs and oligonucleotides teams along with our state-of-the-art facilities and refined workflows to deliver perfect-for-purpose solutions that balance timelines and internal resources with maximum flexibility.
Our end-in-mind approach enables our customers to meet their ever-evolving portfolio needs.